Lieber Jonathan Iinsider trades
In SEC Form 4 filings, Lieber Jonathan I is listed as Chief Financial Officer of Rallybio Corp (RLYB) and Director of Decoy Therapeutics Inc. (DCOY). Lieber Jonathan I reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 13.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RLYBRallybio Corp | Oct 9 | Oct 13 | M | 3,910 | $6.08 | $23,773 | 13,650 | No | Form 4 |
| RLYBRallybio Corp | Oct 9 | Oct 13 | M · derivative | 3,910 | $6.08 | $23,773 | not reported | No | Form 4 |
| RLYBRallybio Corp | Sep 29 | Oct 1 | M | 5,000 | $6.08 | $30,400 | 9,740 | No | Form 4 |
| RLYBRallybio Corp | Sep 29 | Oct 1 | M · derivative | 5,000 | $6.08 | $30,400 | not reported | No | Form 4 |
| DCOYDecoy Therapeutics Inc. | Aug 31 | Sep 2 | A | 2,000 | $0.00 | $0 | 2,002 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.